Review



recombinant mouse interferon γ ifn γ  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    R&D Systems recombinant mouse interferon γ ifn γ
    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments <t>under</t> <t>IFN-γ</t> priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Recombinant Mouse Interferon γ Ifn γ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 615 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Recombinant+Mouse+IFN-gamma+Protein/pmc13094649-113-27-34
    Average 96 stars, based on 615 article reviews
    recombinant mouse interferon γ ifn γ - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "A novel photosensitizer-based photodynamic therapy reprograms the Kynurenine–AhR axis to boost antitumor immunity in breast cancer"

    Article Title: A novel photosensitizer-based photodynamic therapy reprograms the Kynurenine–AhR axis to boost antitumor immunity in breast cancer

    Journal: Redox Biology

    doi: 10.1016/j.redox.2026.104171

    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments under IFN-γ priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Figure Legend Snippet: DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments under IFN-γ priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Techniques Used: Immunofluorescence, Staining, Quantitative RT-PCR, Expressing

    Related Articles

    Recombinant:

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (SigmaAldrich, St. Louis, MO, USA).

    Article Title: Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation
    Article Snippet: .. For some experiments, pregnant mice were injected intraperitoneally with recombinant IFN-γ (485-ML-100/CF, R&D Systems Inc., Minneapolis, MN) 0.01 μg/body from Gd 5.5 to 12.5 and recombinant IL-4 (404-ML-010/CF, R&D Systems Inc.) 1 μg/body from Gd 8.5 to 12.5. ..

    Article Title: Immune profiling of human vestibular schwannoma secretions identifies TNF-α and TWEAK as cytokines with synergistic potential to impair hearing
    Article Snippet: L929 cells ( gift from Dr. Alexei Dekterev, Tufts University School of Medicine, Boston, MA, US) were maintained in Dulbecco’s Modified Eagle Medium (DMEM)/F12 medium, 10% FBS, 1% penicillin/ streptomycin (all, Gibco, Thermo Fisher Scientific, Waltham, MA, USA), and 50 μM of 2- mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) at 37 °C and 5% CO2. .. UB-OC1 cells (Ximbio, London, UK) were maintained in Minimum Essential Medium (MEM) GlutaMAXTM Supplement (Thermo Fisher Scientific, Waltham, MA, USA), 10% FBS, 50 U/mL of recombinant IFN-γ, (R&D Systems, Minneapolis, MN, USA) and 50 μg/ mL of Normocin (InvivoGen, San Diego, CA, USA) at 33 °C and 5% CO2. ..

    Article Title: IFN-γ-Induced intestinal epithelial cell-type-specific programmed cell death: PANoptosis and its modulation in Crohn’s disease
    Article Snippet: .. The culture medium was then replaced every 2 days with differentiation medium containing different concentrations of human recombinant IFN-γ (R&D Systems). ..

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich, St. Louis, MO, USA).

    Article Title: Acute IFN-γ responses drive sensory neuron injury and chronic pain after chikungunya virus infection
    Article Snippet: .. Cells were then stimulated with recombinant IFN-γ (1 ng/mL or 8,4 U/mL; R&D Systems, Cat. #485-MI/CF) or capsaicin (1 μM, positive control) for 60 minutes. .. Neurons were fixed and immunostained for p-ERK (Anti-p-ERK, Cell Signaling, cat. 4370S), ATF3 (Anti-ATF3, NovusBio, cat. NBP1-02935), and NeuN (Anti-NeuN, Cell Signaling, Cat. 24307S).

    Article Title: Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation.
    Article Snippet: .. For some experiments, pregnant mice were injected intraperitoneally with recombinant IFN-γ (485-ML-100/CF, R&D Systems Inc., Minneapolis, MN) 0.01 μg/body from Gd 5.5 to 12.5 and recombinant IL-4 (404-ML-010/CF, R&D Systems Inc.) 1 μg/body from Gd 8.5 to 12.5. ..

    Article Title: Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
    Article Snippet: .. To determine the impact of IFN-γ stimulation on control of intracellular infection, C57BL/6 and C3HeB/FeJ macrophages were incubated for 24 h in either complete DMEM alone or complete DMEM supplemented with 10 ng ml −1 murine recombinant IFN-γ (R and D Systems). ..

    Cell Culture:

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (SigmaAldrich, St. Louis, MO, USA).

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich, St. Louis, MO, USA).

    Control:

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (SigmaAldrich, St. Louis, MO, USA).

    Article Title: Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
    Article Snippet: .. In the experiment, dysfunction was induced in differentiated Caco-2 monolayer cells by treatment with human recombinant IFN-γ (20 ng/mL, R&D Systems, Minneapolis, MN, USA) for 24 h, followed by application of human recombinant TNF-α (10 ng/mL, R&D Systems) to the basolateral compartment for 6 h. After inducing dysfunction in the cell monolayer, the medium in the basolateral chamber was replaced with serum-free DMEM containing 0, 100, or 400 ng/mL sSiglec-9 or SHED-CM, and the cells were cultured for 24 h. The internal control was expressed as cells cultured in DMEM without TNF-α or IFN-γ. .. The barrier function of the cell monolayers was determined by the apical to basolateral flux of 4 kDa fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich, St. Louis, MO, USA).

    Article Title: Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
    Article Snippet: .. To determine the impact of IFN-γ stimulation on control of intracellular infection, C57BL/6 and C3HeB/FeJ macrophages were incubated for 24 h in either complete DMEM alone or complete DMEM supplemented with 10 ng ml −1 murine recombinant IFN-γ (R and D Systems). ..

    Injection:

    Article Title: Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation
    Article Snippet: .. For some experiments, pregnant mice were injected intraperitoneally with recombinant IFN-γ (485-ML-100/CF, R&D Systems Inc., Minneapolis, MN) 0.01 μg/body from Gd 5.5 to 12.5 and recombinant IL-4 (404-ML-010/CF, R&D Systems Inc.) 1 μg/body from Gd 8.5 to 12.5. ..

    Article Title: Inflammatory cytokine interleukin-18 prevents murine miscarriage by inducing appropriate inflammation.
    Article Snippet: .. For some experiments, pregnant mice were injected intraperitoneally with recombinant IFN-γ (485-ML-100/CF, R&D Systems Inc., Minneapolis, MN) 0.01 μg/body from Gd 5.5 to 12.5 and recombinant IL-4 (404-ML-010/CF, R&D Systems Inc.) 1 μg/body from Gd 8.5 to 12.5. ..

    Positive Control:

    Article Title: Acute IFN-γ responses drive sensory neuron injury and chronic pain after chikungunya virus infection
    Article Snippet: .. Cells were then stimulated with recombinant IFN-γ (1 ng/mL or 8,4 U/mL; R&D Systems, Cat. #485-MI/CF) or capsaicin (1 μM, positive control) for 60 minutes. .. Neurons were fixed and immunostained for p-ERK (Anti-p-ERK, Cell Signaling, cat. 4370S), ATF3 (Anti-ATF3, NovusBio, cat. NBP1-02935), and NeuN (Anti-NeuN, Cell Signaling, Cat. 24307S).

    Infection:

    Article Title: Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
    Article Snippet: .. To determine the impact of IFN-γ stimulation on control of intracellular infection, C57BL/6 and C3HeB/FeJ macrophages were incubated for 24 h in either complete DMEM alone or complete DMEM supplemented with 10 ng ml −1 murine recombinant IFN-γ (R and D Systems). ..

    Incubation:

    Article Title: Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
    Article Snippet: .. To determine the impact of IFN-γ stimulation on control of intracellular infection, C57BL/6 and C3HeB/FeJ macrophages were incubated for 24 h in either complete DMEM alone or complete DMEM supplemented with 10 ng ml −1 murine recombinant IFN-γ (R and D Systems). ..



    Similar Products

    recombinant human ifn γ  (MedChemExpress)
    95
    MedChemExpress recombinant human ifn γ
    Recombinant Human Ifn γ, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/IFN-gamma%2C+Mouse/pm42250753-48-39-112
    Average 95 stars, based on 1 article reviews
    recombinant human ifn γ - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    recombinant mouse interferon γ ifn γ  (R&D Systems)
    96
    R&D Systems recombinant mouse interferon γ ifn γ
    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments <t>under</t> <t>IFN-γ</t> priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Recombinant Mouse Interferon γ Ifn γ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Recombinant+Mouse+IFN-gamma+Protein/pmc13094649-113-27-34
    Average 96 stars, based on 1 article reviews
    recombinant mouse interferon γ ifn γ - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    recombinant human interferon α ifn α  (MedChemExpress)
    94
    MedChemExpress recombinant human interferon α ifn α
    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments <t>under</t> <t>IFN-γ</t> priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Recombinant Human Interferon α Ifn α, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/IFN-gamma%2C+Human/pm42143639-32-0-7
    Average 94 stars, based on 1 article reviews
    recombinant human interferon α ifn α - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    recombinant murine ifn γ  (MedChemExpress)
    95
    MedChemExpress recombinant murine ifn γ
    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments <t>under</t> <t>IFN-γ</t> priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Recombinant Murine Ifn γ, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/IFN-gamma%2C+Mouse/pm42142551-72-0-10
    Average 95 stars, based on 1 article reviews
    recombinant murine ifn γ - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    bovine ifn γ  (Kingfisher Biotech)
    94
    Kingfisher Biotech bovine ifn γ
    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments <t>under</t> <t>IFN-γ</t> priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Bovine Ifn γ, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Bovine+IFN+gamma+Recombinant+Protein/pm42107318-61-44-49
    Average 94 stars, based on 1 article reviews
    bovine ifn γ - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    recombinant mouse interferon γ ifn γ  (Beijing Solarbio Science)
    94
    Beijing Solarbio Science recombinant mouse interferon γ ifn γ
    Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + <t>IFN-γ</t> for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
    Recombinant Mouse Interferon γ Ifn γ, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Recombinant+Mouse+Interferon+%7C%3F%2FIFN-%7C%3F%2FIFN+gamma/pmc12809744-60-19-55
    Average 94 stars, based on 1 article reviews
    recombinant mouse interferon γ ifn γ - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    recombinant canine ifn γ  (R&D Systems)
    93
    R&D Systems recombinant canine ifn γ
    Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + <t>IFN-γ</t> for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
    Recombinant Canine Ifn γ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Recombinant+Canine+IFN-gamma+Protein/pmc13129499-59-0-8
    Average 93 stars, based on 1 article reviews
    recombinant canine ifn γ - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    recombinant human ifn γ beta mercaptoethanol gibco 21985023 pma sigma p8139 1  (Thermo Fisher)
    99
    Thermo Fisher recombinant human ifn γ beta mercaptoethanol gibco 21985023 pma sigma p8139 1
    Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + <t>IFN-γ</t> for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
    Recombinant Human Ifn γ Beta Mercaptoethanol Gibco 21985023 Pma Sigma P8139 1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Streptavidin/us12612424-1070-89-93
    Average 99 stars, based on 1 article reviews
    recombinant human ifn γ beta mercaptoethanol gibco 21985023 pma sigma p8139 1 - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    recombinant human ifn γ  (Sino Biological)
    94
    Sino Biological recombinant human ifn γ
    Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + <t>IFN-γ</t> for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
    Recombinant Human Ifn γ, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+ifn+%CE%B3/Human+IFN+gamma+Protein/pm42061510-108-19-24
    Average 94 stars, based on 1 article reviews
    recombinant human ifn γ - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments under IFN-γ priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Redox Biology

    Article Title: A novel photosensitizer-based photodynamic therapy reprograms the Kynurenine–AhR axis to boost antitumor immunity in breast cancer

    doi: 10.1016/j.redox.2026.104171

    Figure Lengend Snippet: DTP-PDT attenuates the IDO–Kyn–AhR axis and relieves immune-suppression in the TME. (A-D) Targeted metabolomics analysis of Trp, Kyn, QA, and 5-HT in cell samples. (E) Targeted metabolomics of Kyn in tumor tissue samples. (F) Levels of Kyn in culture supernatants after the indicated various treatments under IFN-γ priming (n = 3). (G) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue). Scale bar = 20 μm. (H) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells (n = 4). (I-J) Proportion of intratumoral CD8 + T cells (gated on CD3 + T cells, n = 5). (K-L) Proportion of intratumoral Treg cells (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). (M) Representative immunofluorescence images of tumor sections stained for CD3 (green), AhR (red), and DAPI (blue) in the Kyn rescue experiment. Scale bar = 20 μm. (N) RT-qPCR analysis of Cyp1a1, Cyp1b1, and Ahrr mRNA expression in tumor-infiltrating CD3 + T cells from the Kyn rescue experiment (n = 4). (O–P) Proportion of intratumoral CD8 + T cells in the Kyn rescue experiment (gated on CD3 + T cells, n = 5). (Q-R) Proportion of intratumoral Treg cells in the Kyn rescue experiment (gated on CD3 + CD4 + Foxp3 + T cells, n = 5). Data are shown as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: 4T1 cells (5 × 10 5 cells/well) were seeded in 6-well plates and allowed to adhere for 24 h. To activate IDO1 activity, cells were pretreated with recombinant mouse interferon-γ (IFN-γ) (50 ng/mL, 485-MI, R&D System) for 24 h. After IFN-γ priming, cells were treated with DTP-PDT and/or the IDO1 inhibitor (NLG919, Aladdin).

    Techniques: Immunofluorescence, Staining, Quantitative RT-PCR, Expressing

    Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + IFN-γ for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).

    Journal: Bioactive Materials

    Article Title: Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy

    doi: 10.1016/j.bioactmat.2025.12.036

    Figure Lengend Snippet: Reactive oxygen species scavenging capacity of CMA. (A) H 2 O 2 (100 μM) scavenging capacity CMA at 2 h. (B) O 2 − scavenging capacity of CMA at 40 min. (C) •OH scavenging capacity of CMA at 1 min. (D) DPPH (100 μg mL -1 ) scavenging capacity of CMA at 1 h. (E) Fluorescence images of RAW264.7 cells treated with CMA and LPS + IFN-γ for 24 h. Intracellular ROS were stained with DCFH-DA (Green), and nuclei were stained with DAPI (blue). Scale bar = 50 μm. (F) Quantitative analysis of mean DCFH-DA fluorescence intensity. Flow cytometric analysis of ROS expression in: (G) RAW264.7: CMA + LPS; (H) RAW264.7: CMA; (I) SMC: CMA; (J) HUVEC: CMA; (K) RAW264.7: CMA + BAPTA; (L) SMC: CMA + BAPTA; (M) HUVEC: CMA + BAPTA. All treatments were conducted for 24 h. Data are presented as mean ± SD (n = 3–6; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).

    Article Snippet: Baicalein (BAI), copper chloride (CuCl 2 ·2H 2 O), and Atorvastatin (ATV) were purchased from Macklin Inc. Lipopolysaccharides (LPS), recombinant mouse interferon γ (IFN-γ), oxidized low-density lipoprotein (oxLDL), dihydroethidium (DHE), DiI-oxidized low-density lipoprotein (DiI-oxLDL), hematoxylin-eosin (H & E) stain kit, modified Masson's trichrome stain kit, and modified Oil Red O stain kit were obtained from Beijing Solarbio Science & Technology Co., Ltd. Cy5-baicalein was purchased from Xi'an Qiyue Biology.

    Techniques: Fluorescence, Staining, Expressing

    Macrophage reprogramming ability of CMA. (A) Representative optical images of RAW264.7. Scale bar = 50 μm. (B) Confocal laser scanning microscopy images of RAW264.7 cells stained with CD206 antibody, with nuclei counterstained with DAPI. Scale bar = 50 μm. (C) Quantitative analysis of mean CD206 fluorescence intensity. (D) Flow cytometric analysis of CD206 expression in RAW264.7 treated with BAI, Cu-PBS, Cu-MON, ATV, and CMA for 24 h. (E) Relative expression levels of Arg-1, VEGF, TNF-α, and IL-1β in cell supernatants. (F) Flow cytometry scatter plots of iNOS and CD206 expression in RAW264.7 pretreated with LPS + IFN-γ for 24 h followed by treatment with BAI, Cu-PBS, Cu-MON, ATV, and CMA for 24 h. (G–I) Flow cytometric analysis of M1/M2 expression (MFI ratio), iNOs expression, CD206 expression in RAW264.7. (J) Relative expression levels of TGF-β, Arg-1, VEGF, TNF-α, and IL-1β in supernatants from cells treated as in F. Data represent mean ± SD (n = 3–6 independent experiments). Statistical significance: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001 versus Control; ns = not significant.

    Journal: Bioactive Materials

    Article Title: Carrier free oral Co-delivery of atorvastatin via baicalein-copper-network for atherosclerosis therapy through senescence reversal and multi-mechanistic synergy

    doi: 10.1016/j.bioactmat.2025.12.036

    Figure Lengend Snippet: Macrophage reprogramming ability of CMA. (A) Representative optical images of RAW264.7. Scale bar = 50 μm. (B) Confocal laser scanning microscopy images of RAW264.7 cells stained with CD206 antibody, with nuclei counterstained with DAPI. Scale bar = 50 μm. (C) Quantitative analysis of mean CD206 fluorescence intensity. (D) Flow cytometric analysis of CD206 expression in RAW264.7 treated with BAI, Cu-PBS, Cu-MON, ATV, and CMA for 24 h. (E) Relative expression levels of Arg-1, VEGF, TNF-α, and IL-1β in cell supernatants. (F) Flow cytometry scatter plots of iNOS and CD206 expression in RAW264.7 pretreated with LPS + IFN-γ for 24 h followed by treatment with BAI, Cu-PBS, Cu-MON, ATV, and CMA for 24 h. (G–I) Flow cytometric analysis of M1/M2 expression (MFI ratio), iNOs expression, CD206 expression in RAW264.7. (J) Relative expression levels of TGF-β, Arg-1, VEGF, TNF-α, and IL-1β in supernatants from cells treated as in F. Data represent mean ± SD (n = 3–6 independent experiments). Statistical significance: ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001 versus Control; ns = not significant.

    Article Snippet: Baicalein (BAI), copper chloride (CuCl 2 ·2H 2 O), and Atorvastatin (ATV) were purchased from Macklin Inc. Lipopolysaccharides (LPS), recombinant mouse interferon γ (IFN-γ), oxidized low-density lipoprotein (oxLDL), dihydroethidium (DHE), DiI-oxidized low-density lipoprotein (DiI-oxLDL), hematoxylin-eosin (H & E) stain kit, modified Masson's trichrome stain kit, and modified Oil Red O stain kit were obtained from Beijing Solarbio Science & Technology Co., Ltd. Cy5-baicalein was purchased from Xi'an Qiyue Biology.

    Techniques: Confocal Laser Scanning Microscopy, Staining, Fluorescence, Expressing, Flow Cytometry, Control